Search research articles
Contact Us
Filters
Showing results (11-20 of 166) with videos related to
Page
of 17
Sort By:
Molecular Genetics and Metabolism
|
September 18, 2017
The role of epigenetics in lysosomal storage disorders: Uncharted territory
Shahzeb Hassan, Ellen Sidransky, Nahid Tayebi
Biomolecules
|
May 28, 2022
Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction
Chase Chen, Ellen Sidransky, Yu Chen
Neuron
|
February 24, 2017
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki, Wendy Westbroek, Ellen Sidransky
Molecular Genetics and Metabolism
|
January 23, 2021
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes
Emily C Daykin, Emory Ryan, Ellen Sidransky
Macrophage
|
June 20, 2015
New macrophage models of Gaucher disease offer new tools for drug development
Daniel K Borger, Ellen Sidransky, Elma Aflaki
Current Neurology and Neuroscience Reports
|
April 29, 2010
The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders
Arash Velayati, W Haung Yu, Ellen Sidransky
Trends in Molecular Medicine
|
July 5, 2011
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek, Ann Marie Gustafson, Ellen Sidransky
Frontiers in Cell and Developmental Biology
|
June 9, 2020
Small Molecule Chaperones for the Treatment of Gaucher Disease and <i>GBA1</i>-Associated Parkinson Disease
Tae-Un Han, Richard Sam, Ellen Sidransky
Molecular Neurodegeneration
|
August 30, 2019
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy McKinney, Pankaj Sharma, et al.
Molecular Genetics and Metabolism Reports
|
December 23, 2015
Bilateral Femoral Osteolytic Lesions in a Patient with Type 3 Gaucher Disease
Enock Teefe, Jenny Kim, Grisel Lopez, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 166) with videos related to
Sort By:
Page
of 17
Molecular Genetics and Metabolism
|
September 18, 2017
The role of epigenetics in lysosomal storage disorders: Uncharted territory
Shahzeb Hassan, Ellen Sidransky, Nahid Tayebi
Biomolecules
|
May 28, 2022
Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction
Chase Chen, Ellen Sidransky, Yu Chen
Neuron
|
February 24, 2017
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki, Wendy Westbroek, Ellen Sidransky
Molecular Genetics and Metabolism
|
January 23, 2021
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes
Emily C Daykin, Emory Ryan, Ellen Sidransky
Macrophage
|
June 20, 2015
New macrophage models of Gaucher disease offer new tools for drug development
Daniel K Borger, Ellen Sidransky, Elma Aflaki
Current Neurology and Neuroscience Reports
|
April 29, 2010
The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders
Arash Velayati, W Haung Yu, Ellen Sidransky
Trends in Molecular Medicine
|
July 5, 2011
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek, Ann Marie Gustafson, Ellen Sidransky
Frontiers in Cell and Developmental Biology
|
June 9, 2020
Small Molecule Chaperones for the Treatment of Gaucher Disease and <i>GBA1</i>-Associated Parkinson Disease
Tae-Un Han, Richard Sam, Ellen Sidransky
Molecular Neurodegeneration
|
August 30, 2019
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy McKinney, Pankaj Sharma, et al.
Molecular Genetics and Metabolism Reports
|
December 23, 2015
Bilateral Femoral Osteolytic Lesions in a Patient with Type 3 Gaucher Disease
Enock Teefe, Jenny Kim, Grisel Lopez, et al.
Page
of 17